Literature DB >> 21989980

Urea cycle disorders: brain MRI and neurological outcome.

William R Bireley1, Johan L K Van Hove, Renata C Gallagher, Laura Z Fenton.   

Abstract

BACKGROUND: Urea cycle disorders encompass several enzyme deficiencies that can result in cerebral damage, with a wide clinical spectrum from asymptomatic to severe.
OBJECTIVE: The goal of this study was to correlate brain MRI abnormalities in urea cycle disorders with clinical neurological sequelae to evaluate whether MRI abnormalities can assist in guiding difficult treatment decisions.
MATERIALS AND METHODS: We performed a retrospective chart review of patients with urea cycle disorders and symptomatic hyperammonemia. Brain MRI images were reviewed for abnormalities that correlated with severity of clinical neurological sequelae.
RESULTS: Our case series comprises six urea cycle disorder patients, five with ornithine transcarbamylase deficiency and one with citrullinemia type 1. The observed trend in distribution of brain MRI abnormalities as the severity of neurological sequelae increased was the peri-insular region first, extending into the frontal, parietal, temporal and, finally, the occipital lobes. There was thalamic restricted diffusion in three children with prolonged hyperammonemia. Prior to death, this site is typically reported to be spared in urea cycle disorders.
CONCLUSION: The pattern and extent of brain MRI abnormalities correlate with clinical neurological outcome in our case series. This suggests that brain MRI abnormalities may assist in determining prognosis and helping clinicians with subsequent treatment decisions.

Entities:  

Mesh:

Year:  2011        PMID: 21989980     DOI: 10.1007/s00247-011-2253-6

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  27 in total

1.  Neurological outcome of patients with ornithine carbamoyltransferase deficiency.

Authors:  P Nicolaides; D Liebsch; N Dale; J Leonard; R Surtees
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

2.  CT and MRI in a girl with late-onset ornithine transcarbamylase deficiency: case report.

Authors:  S K Bajaj; G Kurlemann; G Schuierer; P E Peters
Journal:  Neuroradiology       Date:  1996-11       Impact factor: 2.804

3.  MRI in a case of adult-onset citrullinemia.

Authors:  Y F Chen; Y C Huang; H M Liu; W L Hwu
Journal:  Neuroradiology       Date:  2001-10       Impact factor: 2.804

4.  Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats.

Authors:  H Takahashi; R C Koehler; S W Brusilow; R J Traystman
Journal:  Am J Physiol       Date:  1991-09

5.  Increased detectability of alpha brain glutamate/glutamine in neonatal hypoxic-ischemic encephalopathy.

Authors:  Y Pu; Q F Li; C M Zeng; J Gao; J Qi; D X Luo; S Mahankali; P T Fox; J H Gao
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

6.  Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

Authors:  B A McCullough; M Yudkoff; M L Batshaw; J M Wilson; S E Raper; M Tuchman
Journal:  Am J Med Genet       Date:  2000-08-14

7.  Magnetic resonance imaging in late-onset ornithine transcarbamylase deficiency.

Authors:  Aki Kurihara; Jun ichi Takanashi; Mika Tomita; Kazuhiko Kobayashi; Atsushi Ogawa; Masaki Kanazawa; Shigenori Yamamoto; Yoichi Kohno
Journal:  Brain Dev       Date:  2003-01       Impact factor: 1.961

8.  1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency.

Authors:  A L Gropman; S T Fricke; R R Seltzer; A Hailu; A Adeyemo; A Sawyer; J van Meter; W D Gaillard; R McCarter; M Tuchman; M Batshaw
Journal:  Mol Genet Metab       Date:  2008-07-26       Impact factor: 4.797

9.  Transient visual loss in ornithine transcarbamoylase deficiency.

Authors:  N G Snebold; J F Rizzo; S Lessell; R C Pruett
Journal:  Am J Ophthalmol       Date:  1987-10-15       Impact factor: 5.258

10.  1H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations.

Authors:  Andrea L Gropman; Rebecca R Seltzer; Marc Yudkoff; Alice Sawyer; John VanMeter; Stanley T Fricke
Journal:  Mol Genet Metab       Date:  2008-02-11       Impact factor: 4.797

View more
  11 in total

Review 1.  Advances in urea cycle neuroimaging: Proceedings from the 4th International Symposium on urea cycle disorders, Barcelona, Spain, September 2013.

Authors:  Ileana Pacheco-Colón; Stanley Fricke; John VanMeter; Andrea L Gropman
Journal:  Mol Genet Metab       Date:  2014-05-20       Impact factor: 4.797

Review 2.  Clinical 1H MRS in childhood neurometabolic diseases - part 2: MRS signatures.

Authors:  Matthew T Whitehead; Lillian M Lai; Stefan Blüml
Journal:  Neuroradiology       Date:  2022-02-28       Impact factor: 2.804

Review 3.  Fifteen years of urea cycle disorders brain research: Looking back, looking forward.

Authors:  Kuntal Sen; Matthew Whitehead; Carlos Castillo Pinto; Ljubica Caldovic; Andrea Gropman
Journal:  Anal Biochem       Date:  2021-10-09       Impact factor: 3.365

Review 4.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

Review 5.  Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015).

Authors:  Giulio Zuccoli; Michael Paul Yannes; Raffaele Nardone; Ariel Bailey; Amy Goldstein
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

Review 6.  Neonatal neuroimaging findings in inborn errors of metabolism.

Authors:  Andrea Poretti; Susan I Blaser; Maarten H Lequin; Ali Fatemi; Avner Meoded; Frances J Northington; Eugen Boltshauser; Thierry A G M Huisman
Journal:  J Magn Reson Imaging       Date:  2012-05-07       Impact factor: 4.813

Review 7.  Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue.

Authors:  Kuntal Sen; Afrouz A Anderson; Matthew T Whitehead; Andrea L Gropman
Journal:  Front Neurol       Date:  2021-04-28       Impact factor: 4.086

8.  The Application of Neurodiagnostic Studies to Inform the Acute Management of a Newborn Presenting With Sarbamoyl Shosphate Synthetase 1 Deficiency.

Authors:  Meaghan McGowan; Carlos Ferreira; Matthew Whitehead; Sudeepta K Basu; Taeun Chang; Andrea Gropman
Journal:  Child Neurol Open       Date:  2021-01-22

9.  Multimodal imaging in urea cycle-related neurological disease - What can imaging after hyperammonemia teach us?

Authors:  Kuntal Sen; Matthew T Whitehead; Andrea L Gropman
Journal:  Transl Sci Rare Dis       Date:  2020-08-03

10.  Magnetic resonance imaging findings and neurodevelopmental outcomes in neonates with urea-cycle defects.

Authors:  Anna Catherine Gunz; Karen Choong; Murray Potter; Elka Miller
Journal:  Int Med Case Rep J       Date:  2013-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.